Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies
Since COVID-19 became a global pandemic in 2020, the development and application of SARS-CoV-2 vaccines has become an important task to prevent the spread of the epidemic. In addition to the safety and efficacy of COVID-19 vaccines, the adverse reactions caused by vaccines in a small number of peopl...
Main Authors: | Yilai Jia, Boyang Fu, Liping Dong, Mingyi Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-08-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2023.2217076 |
Similar Items
-
Recurrent giant cellulitis-like sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
by: Penelope Hirt, et al.
Published: (2023-05-01) -
Sweet Syndrome Following SARS-CoV2 Vaccination
by: Maria Efenesia Baffa, et al.
Published: (2021-10-01) -
Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination
by: A. Riccomi, et al.
Published: (2024-04-01) -
Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection
by: Huang Liang, et al.
Published: (2022-12-01) -
The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
by: Zhongjie Sun, et al.
Published: (2022-07-01)